Summit Therapeutics Inc. (SMMT) Operating margin 2017–2022
Summit Therapeutics Inc. (SMMT) operating margin by fiscal year — reported operating income divided by reported revenue.
-10225.4%FY2022 · since FY2017: -176.1% → -10225.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -10225.4% | -5461.1 pp |
| FY2021 | -4764.3% | +1420.9 pp |
| FY2020 | -6185.2% | — |
| FY2018 | 9.4% | +185.6 pp |
| FY2017 | -176.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SMMT financial trends
SMMT RevenueSMMT Net incomeSMMT Net marginSMMT Gross profitSMMT Gross marginSMMT Operating incomeSMMT Operating cash flowSMMT Free cash flowSMMT Capital expendituresSMMT Return on equitySMMT Stock buybacksSMMT Dividends paidSMMT Total assetsSMMT Total liabilitiesSMMT Shareholders’ equitySMMT overview →